In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUN/SY 5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime, a
about
Susceptibilities of penicillin- and erythromycin-susceptible and -resistant pneumococci to HMR 3647 (RU 66647), a new ketolide, compared with susceptibilities to 17 other agentsActivities of oral and parenteral agents against penicillin-susceptible and -resistant pneumococci.In vitro selection of one-step mutants of Streptococcus pneumoniae resistant to different oral beta-lactam antibiotics is associated with alterations of PBP2x.Activities of RPR 106972 (a new oral streptogramin), cefditoren (a new oral cephalosporin), two new oxazolidinones (U-100592 and U-100766), and other oral and parenteral agents against 203 penicillin-susceptible and -resistant pneumococci.Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study.MIC and time-kill studies of antipneumococcal activity of GV 118819X (sanfetrinem) compared with those of other agentsSusceptibilities of 228 penicillin- and erythromycin-susceptible and -resistant pneumococci to RU 64004, a new ketolide, compared with susceptibilities to 16 other agents.Antimicrobial activity of DU-6681a, a parent compound of novel oral carbapenem DZ-2640Postantibiotic effect of sanfetrinem compared with those of six other agents against 12 penicillin-susceptible and -resistant pneumococci.Activities of faropenem, an oral beta-lactam, against recent U.S. isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalisOccurrence of pneumococci with resistance or decreased susceptibility to penicillin in southeast Sweden.
P2860
Q33691239-709020C5-ED2E-4C2B-ADBB-3BF3FAB10EC6Q35116103-F09F1E02-13E1-4782-9ED7-4F3DF0AD3C50Q35121849-15202D0F-2CC3-4913-B871-3F0FAC8AE66EQ35122591-7C66113E-D328-41BE-941D-ADD4DB2229E5Q35124415-EC3A9E2D-AD73-4858-B5EF-D7A4D9F1D168Q35131455-7A9B3B95-C01E-4A67-882E-F5AC4C22CC2BQ35135982-B4A724F4-F804-4380-8151-CCD6D4FC13A7Q35136539-A4795B5F-20FD-48EE-B389-86CCC2F2094DQ35138485-C56211CE-E16A-4445-A2A0-B6ADE4322ED7Q39651279-6346BE6F-FDDD-4A38-B221-5B4877EC9CC6Q54184261-6135FCD0-4A29-47E2-80BC-D4229A1012E7
P2860
In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUN/SY 5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime, a
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
In vitro susceptibilities of 1 ...... or, cefpodoxime, cefuroxime, a
@ast
In vitro susceptibilities of 1 ...... or, cefpodoxime, cefuroxime, a
@en
type
label
In vitro susceptibilities of 1 ...... or, cefpodoxime, cefuroxime, a
@ast
In vitro susceptibilities of 1 ...... or, cefpodoxime, cefuroxime, a
@en
prefLabel
In vitro susceptibilities of 1 ...... or, cefpodoxime, cefuroxime, a
@ast
In vitro susceptibilities of 1 ...... or, cefpodoxime, cefuroxime, a
@en
P2093
P2860
P356
P1476
In vitro susceptibilities of 1 ...... or, cefpodoxime, cefuroxime, a
@en
P2093
Appelbaum PC
Spangler SK
P2860
P304
P356
10.1128/AAC.38.12.2902
P407
P577
1994-12-01T00:00:00Z